IL76894A - Aryl-substituted tricyclic pyridinone derivatives,their manufacture and pharmaceutical compositions containing them - Google Patents

Aryl-substituted tricyclic pyridinone derivatives,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL76894A
IL76894A IL76894A IL7689485A IL76894A IL 76894 A IL76894 A IL 76894A IL 76894 A IL76894 A IL 76894A IL 7689485 A IL7689485 A IL 7689485A IL 76894 A IL76894 A IL 76894A
Authority
IL
Israel
Prior art keywords
aryl
manufacture
pharmaceutical compositions
compositions containing
substituted tricyclic
Prior art date
Application number
IL76894A
Other languages
English (en)
Other versions
IL76894A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to IL88046A priority Critical patent/IL88046A/xx
Publication of IL76894A0 publication Critical patent/IL76894A0/xx
Priority to IL88046A priority patent/IL88046A0/xx
Publication of IL76894A publication Critical patent/IL76894A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL76894A 1984-11-06 1985-10-31 Aryl-substituted tricyclic pyridinone derivatives,their manufacture and pharmaceutical compositions containing them IL76894A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL88046A IL88046A (en) 1984-11-06 1985-10-31 Aryl-substituted tricyclic thiazolium derivatives
IL88046A IL88046A0 (en) 1984-11-06 1988-10-14 Tricyclic pyridine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530484 1984-11-06
CH383685 1985-09-05

Publications (2)

Publication Number Publication Date
IL76894A0 IL76894A0 (en) 1986-02-28
IL76894A true IL76894A (en) 1989-06-30

Family

ID=25693960

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76894A IL76894A (en) 1984-11-06 1985-10-31 Aryl-substituted tricyclic pyridinone derivatives,their manufacture and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (2) US4735940A (xx)
EP (2) EP0318682B1 (xx)
JP (1) JPH0692405B2 (xx)
CN (1) CN1016871B (xx)
AR (1) AR242579A1 (xx)
AT (1) ATE51232T1 (xx)
AU (1) AU584132B2 (xx)
CA (1) CA1277659C (xx)
DE (2) DE3587235D1 (xx)
DK (1) DK507685A (xx)
DO (1) DOP1985004378A (xx)
ES (8) ES8705436A1 (xx)
FI (1) FI89049C (xx)
GB (1) GB2169288B (xx)
HU (1) HU205353B (xx)
IE (1) IE58850B1 (xx)
IL (1) IL76894A (xx)
IS (1) IS1469B6 (xx)
MC (1) MC1707A1 (xx)
MY (1) MY103172A (xx)
NO (1) NO171914C (xx)
PT (1) PT81431B (xx)
ZW (1) ZW17385A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate
DE69123090D1 (de) * 1990-07-06 1996-12-19 Yoshitomi Pharmaceutical Kondensierte Thiophenverbindungen und deren Verwendung
CA2058640A1 (en) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Tricyclic pyridone derivative
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
GB9708945D0 (en) * 1997-05-01 1997-06-25 Merck Sharp & Dohme Therapeutic agents
GB0119803D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
GB0119828D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
ES2374458T3 (es) 2006-01-13 2012-02-16 The Trustees Of The University Of Pennsylvania Vacunas y agentes inmunoterapéuticos que utilizan il-15 optimizada en codones, y métodos para utilización de los mismos.
AU2014306271A1 (en) 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1289A1 (fr) * 1978-10-13 1980-07-22 Hoffmann La Roche Phenyl quinolizidines
EP0067565A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Pharmaceutically active compounds
GB8408292D0 (en) * 1984-03-30 1984-05-10 Fujisawa Pharmaceutical Co Quinolizinone compound
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
GB8509435D0 (en) * 1985-04-12 1985-05-15 Beecham Group Plc Intermediates & process
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines

Also Published As

Publication number Publication date
FI89049C (fi) 1993-08-10
US4735940A (en) 1988-04-05
DE3576691D1 (de) 1990-04-26
HU205353B (en) 1992-04-28
IS1469B6 (is) 1991-09-24
JPS61115082A (ja) 1986-06-02
ES548532A0 (es) 1987-05-01
EP0183994A1 (de) 1986-06-11
FI854211A0 (fi) 1985-10-28
PT81431A (en) 1985-12-01
DE3587235D1 (en) 1993-05-06
EP0183994B1 (de) 1990-03-21
ES8800939A1 (es) 1987-12-01
AU584132B2 (en) 1989-05-18
DK507685A (da) 1986-05-07
ES554429A0 (es) 1987-12-01
GB8527196D0 (en) 1985-12-11
JPH0692405B2 (ja) 1994-11-16
GB2169288A (en) 1986-07-09
CN85108120A (zh) 1986-11-05
ES554430A0 (es) 1987-12-01
DK507685D0 (da) 1985-11-04
ZW17385A1 (en) 1986-02-19
ES554426A0 (es) 1987-12-01
ES8800936A1 (es) 1987-12-01
IL76894A0 (en) 1986-02-28
ES554427A0 (es) 1987-12-01
ATE51232T1 (de) 1990-04-15
IE58850B1 (en) 1993-11-17
IE852751L (en) 1986-05-06
ES8705436A1 (es) 1987-05-01
EP0318682B1 (de) 1993-03-31
FI89049B (fi) 1993-04-30
NO171914C (no) 1993-05-19
ES8800934A1 (es) 1987-12-01
AU4924185A (en) 1986-05-15
ES8800933A1 (es) 1987-12-01
ES8800932A1 (es) 1987-12-01
CA1277659C (en) 1990-12-11
US5036066A (en) 1991-07-30
ES8800937A1 (es) 1987-12-01
DOP1985004378A (es) 1991-04-05
MC1707A1 (fr) 1986-09-22
ES8800935A1 (es) 1987-12-01
IS3054A7 (is) 1986-05-07
CN1016871B (zh) 1992-06-03
PT81431B (pt) 1988-03-03
GB2169288B (en) 1989-06-01
NO171914B (no) 1993-02-08
EP0318682A2 (de) 1989-06-07
ES554432A0 (es) 1987-12-01
ES554428A0 (es) 1987-12-01
EP0318682A3 (en) 1989-08-16
AR242579A1 (es) 1993-04-30
NO854404L (no) 1986-05-07
MY103172A (en) 1993-05-29
ES554431A0 (es) 1987-12-01
HUT38638A (en) 1986-06-30

Similar Documents

Publication Publication Date Title
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
IL75855A (en) Quinone derivatives,their production and pharmaceutical compositions containing them
IL71243A0 (en) Furo-(3,4-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
ZA848130B (en) New 6-vinyl-furo-(3,4-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL84765A0 (en) Pyridazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL76894A (en) Aryl-substituted tricyclic pyridinone derivatives,their manufacture and pharmaceutical compositions containing them
IL69497A0 (en) Desoxyuridine derivatives,their production and pharmaceutical compositions containing them
IL75219A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them
IL72218A0 (en) Spirosuccinimide derivatives,their production and pharmaceutical compositions containing them
IL74043A (en) 8alhpa-acylaminoergolines,their production and pharmaceutical compositions containing them
IL83049A0 (en) 4-pyridone derivatives,their manufacture and pharmaceutical compositions containing them
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
IL70772A0 (en) Pyrrolidinone derivatives,their manufacture and pharmaceutical compositions containing them
IL86394A0 (en) Pyridine derivatives,their manufacture and pharmaceutical compositions containing them
IL71711A0 (en) Pyrimidone derivatives,their manufacture and pharmaceutical compositions containing them
IL75825A0 (en) Phenylquinoline derivatives,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
IL73810A (en) 4,5,6,7-tetrahydrothiazolo-(5,4-c)pyridine derivatives,their preparation and pharmaceutical compositions containing them
ZA838435B (en) 2-piperazinyl-quinazoline derivatives,their production and pharmaceutical compositions containing them
IL74880A0 (en) Tricyclic imidazole derivatives,their manufacture and pharmaceutical compositions containing them
IL72757A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
GB2169291B (en) 8a-acylaminoergolines, their production and pharmaceutical compositions containing them
IL73429A0 (en) Tricyclic thiadiazinone derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force